期刊文献+

甲状腺功能正常的甲状腺相关眼病患者情绪及生活质量的研究 被引量:6

Study on emotions and quality of life in patients with thyroid-associated ophthalmopathy
下载PDF
导出
摘要 目的初步探讨甲状腺相关眼病(TAO)对患者焦虑抑郁情绪及生活质量的影响。方法纳入38例甲状腺功能正常的TAO患者及34例健康对照者,以欧洲Graves眼病(GO)专家组(EUGOGO)管理共识为标准将TAO患者分为病情轻度组及病情中重度组,分别运用相关量表对受试者予以焦虑抑郁情绪及生活质量评估。结果 TAO患者焦虑、抑郁发生率分别可达36.8%、28.9%,较健康对照组8.8%、5.9%的发生率显著增高(P<0.05),而TAO患者生活质量评分低于对照组(P<0.01);亚组分析显示女性焦虑、抑郁发生率分别为50.0%、45.5%,显著高于男性18.8%、6.3%的发生率(P<0.05),生活质量评分则低于男性(P<0.05);与TAO病情轻度组相比,病情中重度组焦虑(21.7%vs.60.0%,P<0.05)及抑郁(8.7%vs.60.0%,P<0.01)情绪发生率更高,同时生活质量评分更低(P<0.05)。结论 (1)TAO对患者的情绪及生活质量均有显著影响。(2)TAO患者焦虑及抑郁情绪发生率明显升高,生活质量明显降低;女性患者较男性患者更易出现焦虑及抑郁情绪,生活质量更容易受到TAO影响。(3)TAO患者病情越严重,焦虑抑郁情绪越明显,生活质量越低。 Objective To evaluate the emotions and quality of life in the patients with thyroid-associated ophthalmopathy (TAO). Methods 38 TAO patients with normal thyroid function and 34 healthy subjects were recruited. The patients with TAO were further divided into the mild and moderate-severe group by EUGOGO criteria. The depressive and anxious status and quality of life of all subjects were assessed by the rating scales. Results The incidence rate of anxiety and depression in the patients with TAO was 36.8~//oo and 28.9~ separately, which were higher than 8.8~ and 5.9% in the controls(P^0.05) ,but the quality of life scores in TAO patients were lower than those in the controls(P^0.05). The subgroup analysis indicated that the incidence rate of anxiety and depression in female TAO patients was 50.0% and 45.5 ~//0 separately, which were higher than that in male TAO pa- tients 18.8G vs. 6.3^(P^0.05) ,but the quality of life scores in female TAO patients were lower than those in male TAO pa- tients(P^0.05). Compared with the mild-moderate group, an obviously higher incidence rate of anxiety(21.7 ~ vs. 60.0 %, P~ 0.05) and depression(8.7% vs. 60.0%, P^0. 05) were observed in the severe group with the lower quality of life scores(P~ 0.05). Conclusion (1) TAO affects the emotions and the quality of life of TAO patients. (2) TAO patients have a statistically higher incidence rate of anxiety and depression and a lower quality of life,this phenomenon is more obvious in female patients. (3) The patients with severe TAO are more likely to have anxiety and depression,as well as a lower quality of life.
出处 《重庆医学》 CAS CSCD 北大核心 2013年第26期3122-3124,共3页 Chongqing medicine
关键词 甲状腺相关眼病 焦虑 抑郁 生活质量 thgroid-associated ophthalmopathy anxiety depression quality of life
  • 相关文献

参考文献16

  • 1Ginsberg J. Diagnosis and management of Gravesr disease[J]. CMAJ,200a, 168(5):575-585.
  • 2Maheshwari R, Weis E. Thyroid associated orbitopathy[J]. Indian J Ophthalmol,2012,60(2) :87-93.
  • 3Bartley GB,Fatourechi V, Kadrmas EF, et al. Clinical fea- tures of gravesr ophthalmopathy in an incidence cohort [J]. Am J Ophthalmol,1996,121(3) :284-290.
  • 4Farid M, Roch-Levecq AC, Levi L, et al. Psychological disturbance in graves ophthalmopathy[J]. Arch Ophthal- mol,2005,123(4) :491-496.
  • 5Park J J, Sullivan TJ, Mortimer RH, et al. Assessing quali- ty of life in Australian patients with graves: ophthalmopa- thy[J]. Br J Ophthalmol, 2004,88 ( 1 ) : 75-78.
  • 6Kahaly GJ, Hardt J, Petrak F, et al. Psychosocial factors in subjects with thyroid associated ophthalmopathy[J]. Thyroid, 2002,12(3) : 237-239.
  • 7Terwee C, Wakelkamp I, Tan S, et al. Long-term effects of gravesr ophthalmopathy on health-related quality of life [J]. Eur J Endocrinol,2002,146(6) :751-757.
  • 8Bartalena L, Baldeschi L, Dickinson A, et al. Consensus statement of the European Group on graves' orbitopathy (EUGOGO) on management of GO[J]. Eur J Endocri- nol, 2008,158 (3) : 273-285.
  • 9Kahaly GJ,Petrak F, Hardt J, et al. Psychosocial morbidi- ty of gravesJ orbitopathy [J]. Clinical Endocrinology, 2005,63(4) : 395-402.
  • 10于艳茹,孙斌,张朝霞.甲状腺相关性眼病对患者焦虑及抑郁情绪影响的初步研究[J].中国医疗前沿,2011,6(2):61-62. 被引量:5

二级参考文献18

  • 1沈渔邮.精神病学[M].第4版.北京:人民卫生出版社,2005:327-329.
  • 2Burch HB, Wartofsky L. Graves1 ophthalmopathy:current concepts regarding pathogenesis and management[J]. Endocr Rev,1993,14:747 793.
  • 3Weetman AP. Thyroid-associated eye disease: pathophysiology[J]. Lancet, 1991, 338 :25-28.
  • 4Egle UT, Kahaly G J, Petrak F, et al. The relevance of physical and psychosocial factors for the quality of life in patients with thyroid-associated orbitopathy(TAO)[J].Exp Clin Endocrinol Diabetes, 1999,107(suppl 5):S168-S171.
  • 5Farid M, Roch-Levecq AC, Levi L, et al. Psychological disturbance in graves ophthalmopathy[J].Arch Ophthalmol,2005, 123 (4): 491-496.
  • 6Park JJ, Sullivan TJ, Mortimer RH, et al. Assessing quality of lile in Australian patients with Graves' ophthalmopathy[Jl.Br J Ophthalmol, 2004,88:75-78.
  • 7Kahaly G J, Petrak F, Hardt J, et al. Psychosocial morbidity of Graves1 orbitopathy[J]. Clinical Endocmlology,2005,63(4):395-402.
  • 8Coulter I, Frewin S, Krassas GE, et al. Psychological implications of Graves1 orbitopathy[J].Eur J Endocrinol,2007, 157:127 31.
  • 9Farid M, Roch-Levecq AC, Levi L, et al. Psychological Disturbance in Graves1 Ophthalmopathy[J].Arch Ophthalmol, 2005,123 ..491-496.
  • 10采国祥.眼眶病学[M]北京:人民卫生出版社,1999342.

共引文献13

同被引文献52

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部